Science Park 408
1098 XH
AMSTERDAM
Mavacamten for patients with Hypertrophic Cardiomyopathy (HCM) and other medicines for heart diseases
Myokardia pioneers a precision medicine approach to treating cardiomyopathies and other forms of heart failure that results from biomechanical defects in cardiac muscle contraction. Myokardia Netherlands serves as the European Headquarters and is focused on bringing the first product mavacamten to HCM patients in Europe